Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina

Growth Factors

Volumn 33, Issue 3, 2015, Pages 192-199

  Jiang, Youde ^a   Zhang, Qiuhua ^b   Steinle, Jena J ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Beta adrenergic receptor; diabetic retinopathy; VEGF

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; PROTEIN KINASE C DELTA; PROTEIN KINASE C ZETA; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN; ISOENZYME; NORADRENALIN; NOS3 PROTEIN, RAT; PHENETHYLAMINE DERIVATIVE; PKCQ PROTEIN, RAT; PROTEIN KINASE C; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL; SIGNAL TRANSDUCTION; TOPICAL TREATMENT; ANALOGS AND DERIVATIVES; ANIMAL; CYTOLOGY; DIABETIC RETINOPATHY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LEWIS RAT; MACULAR EDEMA; METABOLISM; PATHOLOGY; RETINA; RNA INTERFERENCE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; ISOENZYMES; MACULAR EDEMA; MALE; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; PHENETHYLAMINES; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS; RATS, INBRED LEW; RETINA; RNA INTERFERENCE; RNA, SMALL INTERFERING; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942409865     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2015.1054990     Document Type: Article

References (31)

1. Agarwal A, Sarwar S, Sepah YJ, Nguyen QD. 2015. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era? Curr Opin Ophthalmol 26: 177-183
2. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. 2010. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59: 2872-2882
3. Barbieri A, Palma G, Rosati A, Giudice A, Falco A, Petrillo A, Petrillo M, et al. 2012. Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth. J Cell Mol Med 16: 920-926
4. Dal Monte M, Cammalleri M, Mattei E, Filippi L, Bagnoli P. 2015. Protective effects of beta1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 56: 59-73
5. Dal Monte M, Filippi L, Bagnoli P. 2013. Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants. Naunyn Schmiedebergs Arch Pharmacol 386: 269-278
6. Dal Monte M, Martini D, Latina V, Pavan B, Filippi L, Bagnoli P. 2012. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 53: 2181-2192
7. Das A, Stroud S, Mehta A, Rangasamy S. 2015. New treatments for diabetic retinopathy. Diabetes Obes Metab 17: 219-230
8. Frey T, Antonetti DA. 2011. Alterations to the blood-retinal barrier in diabetes: Cytokines and reactive oxygen species. Antioxid Redox Signal 15: 1271-1284
9. Geraldes P, King GL. 2010. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319-1331
10. Googe J, Brucker AJ, Bressler NM, Qin H, Aiello LP, Antoszyk A, Beck RW, et al.; Diabetic Retinopathy Clinical Research Network. 2011. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina 31: 1009-1027
11. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. 2006. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 47: 5106-5115
12. Jarajapu YP, Cai J, Yan Y, Li Calzi S, Kielczewski JL, Hu P, Shaw LC, et al. 2012. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One 7: e39398
13. Jiang Y, Zhang Q, Liu L, Tang J, Kern TS, Steinle JJ. 2013. Beta2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype. PLoS One 8: e70555
14. Kielczewski JL, Jarajapu Y, McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, et al. 2009. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105: 897-905
15. Kielczewski JL, Li Calzi S, Shaw LC, Cai J, Qi X, Ruan Q, Wu L, et al. 2011. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest Ophthalmol Vis Sci 52: 8278-8286
16. Kim JH, Kim JH, Jun HO, Yu YS, Kim KW. 2010. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am J Pathol 176: 1517-1524
17. Koizumi K, Poulaki V, Doehmen S, Welsandt G, Radetzky S, Lappas A, Kociok N, et al. 2003. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest Ophthalmol Vis Sci 44: 2184-2191
18. Munoz YC, Gomez GI, Moreno M, Solis CL, Valladares LE, Velarde V. 2012. Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway. Horm Metab Res 44: 625-631
19. Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, Jonet L, Savoldelli M, et al. 2011. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: Role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol 179: 942-953
20. Omri S, Behar-Cohen F, Rothschild PR, Gelize E, Jonet L, Jeanny JC, Omri B, Crisanti P. 2013. PKCzeta mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. PLoS One 8: e81600
21. Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, et al. 2011. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism. Int J Cancer 128: 2306-2316
22. Sharifpanah F, Saliu F, Bekhite MM, Wartenberg M, Sauer H. 2014. Beta-adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling. Cell Tissue Res 358: 443-452
23. Simo R, Hernandez C., European Consortium for the Early Treatment of Diabetic R. 2014. Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives. Trends Endocrinol Metab 25: 23-33
24. Song HB, Jun HO, Kim JH, Yu YS, Kim KW, Kim JH. 2014. Suppression of protein kinase C-zeta attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy. Biochem Biophys Res Commun 444: 63-68
25. Stati T, Musumeci M, Maccari S, Massimi A, Corritore E, Strimpakos G, Pelosi E, et al. 2014. Beta-blockers promote angiogenesis in the mouse aortic ring assay. J Cardiovasc Pharmacol 64: 21-27
26. Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, Antonetti DA. 2012. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. Biochem J 446: 455-467
27. Wang L, Wu B, Sun Y, Xu T, Zhang X, Zhou M, Jiang W. 2010. Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation. Br J Anaesth 104: 606-612
28. Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, Liu L, Soderland C, et al. 2012. Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels. Invest Ophthalmol Vis Sci 53: 3004-3013
29. Zhang Q, Jiang Y, Miller MJ, Peng B, Liu L, Soderland C, Tang J, et al. 2013. IGFBP-3 and TNF-alpha regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci 54: 5376-5384
30. Zhang Q, Jiang Y, Steinle JJ. 2015. IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels. Mol Vis 21: 604-611
31. Zhang Q, Steinle JJ. 2014. IGFBP-3 inhibits TNF-alpha production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis. Microvasc Res 95: 76-81